THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Irenic Capital Management LP's Holding History (CIK: 0001929389)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,760,948 Value ($000) $51,657 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 2,760,948 Value ($000) $40,310 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 2,760,948 Value ($000) $30,453 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 2,760,948 Value ($000) $24,655 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 2,760,948 Value ($000) $25,981 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 2,760,948 Value ($000) $22,253 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 2,760,948 Value ($000) $23,413 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 2,760,948 Value ($000) $24,766 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 2,760,948 Value ($000) $31,033 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 2,760,948 Value ($000) $23,827 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 2,760,948 Value ($000) $28,576 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 2,764,048 Value ($000) $29,990 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 1,700,937 Value ($000) $19,085 Avg Close $10.51 Range $9.56 - $11.83